Skip to main content
Clinical Trials/NCT01938027
NCT01938027
Completed
Not Applicable

A Pilot Study for the Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision

National Cancer Center, Korea1 site in 1 country12 target enrollmentSeptember 2013
ConditionsRectal Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rectal Cancer
Sponsor
National Cancer Center, Korea
Enrollment
12
Locations
1
Primary Endpoint
Total Mesorectal Excision(TME) quality
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is evaluation of the safety and the efficacy of transanal total mesorectal excision.

Detailed Description

Subjects will have their rectal cancer removed using a technique combining surgery through the anus and standard laparoscopy. Transanal visualization will be using endoscopy. At the end of the procedure, the rectum will be removed though the anus or ileostomy formation site, the bowel will be re-connected to the anus, and a temporary diverting stoma will be created, which is standard of care following surgery for this type of cancer.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
August 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jae Hwan Oh

Head of Center for Colorectal Cancer, National Cancer Center

National Cancer Center, Korea

Eligibility Criteria

Inclusion Criteria

  • age: 20-80 years
  • biopsy-proven adenocarcinoma of the rectum
  • clinical staging, (T1 or T2 or T3) with N0M0
  • Rectal cancer located 4-12 cm from the anal verge
  • ECOG performance status 2 or less

Exclusion Criteria

  • Synchronous colon cancer or other malignancy
  • Obstructing rectal cancer
  • Pregnant or breast-feeding
  • Receiving any other study agents
  • Fecal incontinence
  • History of prior colorectal cancer or inflammatory bowel disease
  • BMI \> 30
  • T3 rectal cancer not treated preoperatively with full-course chemoradiation

Outcomes

Primary Outcomes

Total Mesorectal Excision(TME) quality

Time Frame: 1-5 years

The quality of the mesorectum was determined using pathology reports and scored using three grades: * Complete: intact mesorectum with only minor irregularities of a smooth mesorectal surface. No defect is deeper than 5 mm, and there is no coning toward the distal margin of the specimen. There is a smooth circumferential resection margin on slicing. * Nearly complete: moderate bulk to the mesorectum, but irregularity of the mesorectal surface. Moderate coning of the specimen is allowed. At no site is the muscularis propria visible, with the exception of the insertion of the levator muscles. * Incomplete: little bulk to mesorectum with defects down onto muscularis propria and/or very irregular circumferential resection margin.

Secondary Outcomes

  • 30-day postoperative complications, No. of harvested LN(1-5 years)

Study Sites (1)

Loading locations...

Similar Trials